Cardiovascular Health And Risk Modification in Family Health Teams - Full Text View

Sponsored by:	University of Toronto
Information provided by:	University of Toronto
ClinicalTrials.gov Identifier:	NCT00787306

Purpose

Cardiovascular diseases remain the main cause of mortality in Canada. While effective interventions are available for reducing the risk of cardiovascular disease,there continue to be gaps between the potential reduction in risk that could be achieved by effectively managing these risk factors and levels of risk factor control currently in clinical practice. This study will evaluate the ability of a different model of risk factor care using other health providers assisting family doctors, along with information aids for patients and health professionals,to achieve better levels of cardiovascular risk fatror control in adults.

Condition	Intervention	Phase
Cardiovascular Risk Factors Hypertension Hyperlipidemia Diabetes	Behavioral: Active risk factor surveillance	Phase III

MedlinePlus related topics: High Blood Pressure

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Prevention, Randomized, Open Label, Parallel Assignment, Efficacy Study
Official Title:	Multidisciplinary Cariovascular Health And Risk Modification in Family Mealth Teams

Further study details as provided by University of Toronto:

Primary Outcome Measures:

mean systolic blood pressure [ Time Frame: 6 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:

Proportion of adults with 3 CV risk factors under optimal control [ Time Frame: 6 months ] [ Designated as safety issue: No ]

Estimated Enrollment:	480
Study Start Date:	September 2008
Estimated Study Completion Date:	July 2009
Estimated Primary Completion Date:	May 2009 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
Active monitoring: Active Comparator Multi-disciplinary chronic disease management and decision aid intervention	Behavioral: Active risk factor surveillance Cardiovascualr risk status assessment followed by active surveillance and physician review where risk factor control is suboptimal
Control: No Intervention Usual care in a wait-list control arm that receives the experimental intervantion after 6 months.	Behavioral: Active risk factor surveillance Cardiovascualr risk status assessment followed by active surveillance and physician review where risk factor control is suboptimal

Eligibility

Ages Eligible for Study:	50 Years to 80 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria:

adults 50 to 80 years of age
having attending a family medicine clinic for more than one year

Exclusion Criteria:

not able to participate for one year
not able to read English
requires house calls
nursing home resident
cognitive impairment
current chest pain or symptoms of active coronary heart disease

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00787306

Contacts

Contact: Warren J McIsaac, MD	416-586-3190	wmcisaac@mtsinai.on.ca
Contact: Tijana Dragicevic, BSc	416-586-4800 ext 2829	TDragicevic@mtsinai.on.ca

Locations

Canada, Ontario
Granovsky Gluskin Family Medicine Cwntre	Recruiting
Toronto, Ontario, Canada, M5T 3L9
Principal Investigator: Warren J McIsaac, MD

Sponsors and Collaborators

University of Toronto

Investigators

Principal Investigator:

Warren J McIsaac, MD

Granovsky Gluskin Family Medicine Centre, Mount Sinai Hospital

More Information

Responsible Party:	Granovsky Gluskin Family Medicine Centre, Mount Sinai Hospital ( Dr.Warren J. McIsaac )
Study ID Numbers:	MOH-1048
Study First Received:	November 6, 2008
Last Updated:	December 1, 2008
ClinicalTrials.gov Identifier:	NCT00787306
Health Authority:	Canada: Ethics Review Committee

Keywords provided by University of Toronto:

chronic disease management
decision aids
cardiovascular risk factors

Study placed in the following topic categories:

Metabolic Diseases
Hyperlipidemias
Vascular Diseases
Diabetes Mellitus
Chronic Disease

Metabolic disorder
Dyslipidemias
Lipid Metabolism Disorders
Hypertension

Additional relevant MeSH terms:

Cardiovascular Diseases

ClinicalTrials.gov processed this record on January 16, 2009